ArticleCancer immunology, immunotherapy : CII2025

Safety and efficacy of neoadjuvant therapy with tislelizumab plus chemotherapy for locally advanced head and neck squamous cell carcinoma: a single-arm, retrospective study.

Haifeng Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.